1 / 26

Steven J. Shapiro Infertility Prevention Project Coordinator CDC/NCHHSTP/DSTDP/PTB (proposed)

Region II Infertility Prevention Project Advisory Committee November 1-2, 2006 New York City, New York. Steven J. Shapiro Infertility Prevention Project Coordinator CDC/NCHHSTP/DSTDP/PTB (proposed)

sblocker
Télécharger la présentation

Steven J. Shapiro Infertility Prevention Project Coordinator CDC/NCHHSTP/DSTDP/PTB (proposed)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Region IIInfertility Prevention Project Advisory CommitteeNovember 1-2, 2006New York City, New York Steven J. Shapiro Infertility Prevention Project Coordinator CDC/NCHHSTP/DSTDP/PTB (proposed) Disclaimer: The findings and conclusions in this presentation are those of the author and do not necessarily represent the views of the Centers for Disease Control and Prevention.

  2. Topics CDC Update: • Personnel • Budget • Ongoing Projects • Performance Measures

  3. IPP Personnel • Laura Shelby

  4. Budget 2006 • Flat Funding for STD Prevention • $161 Million FY 2006 • $106 million to grantees • 1% Katrina Rescission • Total Cut 2.97% • 2007 Budget Unknown • Continuing Resolution 11-17-06 • 2006 Funding Levels

  5. Ongoing Projects • EPT Catalog of Statutes • Male Screening Consultation • WebPage • Infertility Prevention Workgroup • Performance Measures • CSPS • Infrastructure

  6. Male Screening Consultation • Across branch development of questions of interest: • What is the effectiveness of screening men in various venues to identify undiagnosed chlamydia infection? • Can we identify behavioral or demographic characteristics such as age that can be used to target men at high risk for chlamydia infection? • What do models and cost-effectiveness studies on male chlamydia screening tell us? • What data are there on partner management practices for female partners of men found to have chlamydia? • What is the relative performance of non-invasive tests (i.e.- LE vs. NAAT) for male chlamydia screening in different settings?

  7. Male Screening Consultation • Tables of evidence produced and presented by authors • Four breakout Groups • Venues and Re-infection Issues • Demographics and Behavior • Cost-effectiveness and Partner Management • Laboratory

  8. Male Screening Consultation • Twenty-one Recommendations • Large Group Discussion • Level of Support • Individual Opinion • Strength of Recommendation • Thank You Letter • Summary Document of the meeting notes and compilation of results is complete and has been distributed to the participants for review • Dear Colleague Letter is in draft form

  9. Web Page • Live 10-5-06 • Infertility & STDs http://www.cdc.gov/std/infertility/default.htm • IPP http://www.cdc.gov/std/infertility/ipp.htm

  10. Infertility Prevention Workgroup • Review • Charge • IPW SubCommittees • 2 page Outlines • Broad Action Areas • 26 to 11 • Development of Brief Response papers • Discussion Meeting June 16 • Priority Areas to Dr. Douglas

  11. IPW • Summary of IPW Submission: • Common theme: • Should the Division support increased screening of females under the age of 26 for Ct in public and private sectors? • Supporting Priorities • Should the Division develop and implement a social marketing campaign based on the benefits of Ct screening • Should the Division attempt to monitor the % sexually active females <26 who have been screened for Ct in the past year

  12. IPW • Priorities as Core Functions- • Focus on improved quality of data from the current prevalence monitoring system. • Develop a web site for infertility prevention to include all existing guidelines and tools. • Develop new and/or revised screening guidelines for GC and Ct for males and females.

  13. IPW • Division Process • Each Branch and Workgroup submitted proposals • Two division retreats • 42 to 13 to 8 to 4 • Increased CT Screening • HPV Surveillance • Data Improvement • Human Capital • Division Leadership Review

  14. Performance Measures Activities • Expansion of CSPS Performance Measures • Timeliness of treatment for gonorrhea and chlamydia in women who test positive in STD clinics • Gender of Sex Partner information • Infrastructure Performance Measures • Proportion of family planning clinics adhering to regional chlamydia screening criteria • Screening coverage estimate among sexually active 15-19 year old women in FP clinics

  15. PM Activities (2) • Performance Measures Database • Continued development of Technical Assistance and Reports section • Learning tours- Baltimore and Los Angeles • Database available for aggregate January-June 2006 data entry until October 31, 2006. Changes after 11-1-06 will be reviewed, approved, and entered by project area consultant.

  16. Performance MeasureIPP CS1 Among clients of IPP Family Planning clinics, the proportion of women with positive chlamydia tests treated within 14 and 30 days of the date of specimen collection.

  17. IPP CS 1 (Chlamydia) Results

  18. Performance MeasureIPP CS2 Among clients of IPP Family Planning clinics, the proportion of women with positive gonorhea tests treated within 14 and 30 days of the date of specimen collection.

  19. IPP CS 2 (Gonorrhea) Results

  20. Performance MeasureCSPS MLS1 Proportion of female admittees to large juvenile detention centers tested for chlamydia.

  21. CSPS MLS1 (JDC Screening) Results

  22. Questions?

More Related